Memorial Sloan Kettering Cancer Center researchers have managed to grow organoids derived from human prostate cancer tumors in the laboratory, which could provide a perfect platform to test cancer drugs and personalize cancer treatment. The researchers, whose results were published today in emCell/em, successfully grew six prostate cancer organoids from biopsies of patients with metastatic prostate cancer and a seventh organoid from a patient's circulating ...Friday 5 September 2014
Ability to Grow Prostate Cancer Organoids Provides Researchers With Precision Medicine Tool to Test New Drugs
Memorial Sloan Kettering Cancer Center researchers have managed to grow organoids derived from human prostate cancer tumors in the laboratory, which could provide a perfect platform to test cancer drugs and personalize cancer treatment. The researchers, whose results were published today in emCell/em, successfully grew six prostate cancer organoids from biopsies of patients with metastatic prostate cancer and a seventh organoid from a patient's circulating ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment